Volume 17, Number 11—November 2011
Letter
Congenital Syphilis, Réunion Island, 2010
Table
Year of diagnosis |
Mother
|
|
Child
|
|||||
---|---|---|---|---|---|---|---|---|
Age, y | Time of syphilis screening | Duration of treatment, d | Presence andsatage of disease | Positive serologic titer test results | Gestation, wk | Clinical signs | ||
2008 | 16 | >13 wk gestation | 5 d BD | Probable secondary syphilis at first trimester | TPHA, VDRL, FTA-ABS | 34 | None | |
2008 | 25 | Unknown | 2 d AD | NA | TPHA, VDRL, FTA-ABS | 34 | None | |
2008 | 16 | AD | 14 d AD | Primary syphilis at third trimester | TPHA, VDRL, FTA-ABS | 38 | None | |
2009 | 26 | >13 wk gestation | 17 d BD | NA | TPHA, VDRL, FTA-ABS | 31 | Present | |
2009 | 18 | >13 wk gestation | 2 d BD | NA | TPHA, VDRL | 32 | Present | |
2009 | 22 | >13 wk gestation | 1 d BD | NA | TPHA, VDRL | 32 | Present | |
2009 | 37 | After delivery | 1 d AD | NA | TPHA, VDRL | 38 | None |
*BD, before delivery; TPHA, Treponema pallidum hemagglutination assay; VDRL, Venereal Disease Research Laboratory; FTA-ABS, fluorescent treponemal antibody absorption; AD, after delivery; NA, not applicable.
Page created: October 24, 2011
Page updated: October 24, 2011
Page reviewed: October 24, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.